Breast cancer treatment has come a long way, yet for many patients, the journey remains grueling. Surgery, followed by years of hormone therapy, is the standard approach for estrogen receptor-positive (ER+) breast cancer. While practical, this regimen brings harsh side effects and the looming risk of recurrence. A new experimental drug could change everything. In …
Cancer vaccines have always come with a frustrating catch. Unlike flu shots that work for millions of people, most cancer vaccines need to be custom-made for each patient. Doctors must extract tumor samples, analyze them, and build a vaccine tailored to that specific person’s cancer. By the time all that happens, months have passed, and …
Prostate cancer develops resistance. Treatments work for years, then stop working. Patients who responded well to therapy suddenly face a disease that ignores their medication. Doctors watch helplessly as cancer spreads and becomes lethal in 10 to 20 percent of cases within five years. But researchers at Sanford Burnham Prebys may have found a way …
For decades, a cancer diagnosis has often pushed patients toward a familiar set of choices. Surgeons could cut. Radiation teams could aim beams at diseased tissue. Chemotherapy could move through the body in search of malignant cells. Each path has saved lives, yet each can leave patients facing pain, fatigue, scarring or long recovery. A …
When millions lined up for COVID-19 vaccines during the pandemic, survival meant avoiding a deadly virus. Few could have imagined that same shot might offer protection against something else entirely. Researchers at two major cancer centers have stumbled onto a finding that could reshape how oncologists treat advanced disease. Patients with late-stage lung and skin …